Compare GNT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNT | EDAP |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | France |
| Employees | N/A | 289 |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.5M | 128.9M |
| IPO Year | N/A | 1998 |
| Metric | GNT | EDAP |
|---|---|---|
| Price | $8.86 | $3.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 65.6K | 32.0K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 6.61% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | $9.27 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $5.87 | $1.21 |
| 52 Week High | $9.30 | $5.05 |
| Indicator | GNT | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 56.95 | 38.73 |
| Support Level | $7.76 | $3.19 |
| Resistance Level | $9.30 | $3.44 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 63.27 | 35.34 |
GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.